In today’s Pharmaceutical Executive Daily, the FDA appoints Tracy Beth Høeg as acting CDER director, health systems explore ...

Jaypirca was approved for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who were previously treated with a covalent Bruton ...

Along with appointing Dr. Høeg as head of CDER, FDA also announced its appointment of Karen Murry, M.D., as the new director of the Office of Nonprescription Drugs (ONPD). 1 Dr. Murray’s appointment ...

For manufacturers and health systems alike, proactive partnership consisting of early engagement, mutual understanding, and operational alignment is not only the key to long-term success, but also to ...

Dr. Pazdur’s decision comes just weeks after being appointed as the head of CDER earlier in November this year.His ...

There is one shift that improves translation across modalities. Treat preclinical evidence as if it must stand up inside an ...

In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera ...

Lou Pillai is the founder of Ulivmo and most recently, he was the Head of Data and Digital at Immunomedics (acquired by Gilead). Ehsan Ehsani is a director of consulting at CGI and leader of ...

The main takeaway is that GLP-1s appear to provide kidney protection in a specific, well-defined population, CKD driven by ...

New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...

Along with the deployment and integration the new agentic AI tool, FDA is also launching an agentic AI challenge for its ...

Regeneron announced that it has entered into a global collaboration agreement with Tessera Therapeutics to commercialize and ...